Inhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates of cholesterol synthesis

European Journal of Clinical Investigation

Volumn 24, Issue 11, 1994, Pages 766-772

  MUNRO, E ^a   PATEL, M ^a   CHAN, P ^a   BETTERIDGE, L ^a   CLUNN, G ^a   GALLAGHER, K ^a   HUGHES, A ^a   SCHACHTER, M ^a   WOLFE, J ^a   SEVER, P ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Graft stenosis; isoprenoid synthesis; lovastatin; proliferation; vascular smooth muscle cell.

Indexed keywords

ISOPRENOID; MEVINOLIN;

ARTICLE; BLOOD VESSEL GRAFT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; HUMAN; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

ADENINE; CELL DIVISION; CELLS, CULTURED; CHOLESTEROL; CORONARY DISEASE; FARNESOL; HUMANS; ISOPENTENYLADENOSINE; L-LACTATE DEHYDROGENASE; LOVASTATIN; MEVALONIC ACID; MUSCLE, SMOOTH, VASCULAR; SAPHENOUS VEIN;

EID: 0028099592     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.1994.tb01074.x     Document Type: Review

References (50)

1. Restenosis after successful coronary angioplasty
2. Clinical trials of restenosis after coronary angioplasty
3. Second European consensus document on chronic critical leg ischaemia
4. Graft stenosis: justification for one year surveillance
5. Long term fate of bypass grafts: the CASS and Montreal Heart Institute experiences
6. The vascular pathology of human hepatic allografts
7. Kinetics of cellular proliferation after arterial injury. Endothelial and smooth muscle growth in chronically denuded vessels
8. Experimental models of coronary artery restenosis
9. Effect of lovastatin on intimal hyperplasia after balloon angioplasty: a study in an atherosclerotic hypercholesterolaemic rabbit
10. Prevention of restenosis by lovastatin after successful coronary angioplasty
11. Lovastatin: a new cholesterol lowering agent
12. Relationship between mevalonate and mitogenesis in human fibroblasts stimulated with platelet derived growth factor
13. Effects of mevinolin and mevalonate on cell growth in several transformed cell lines
14. Essential role for mevalonate synthesis in DNA replication
15. Effects of 25‐hydroxycholesterol, cholesterol and isoprenoid derivatives on the G1 progression in Swiss 3T3 cells
16. Regulation of the mevalonate pathway
17. res is modified by a farnesyl isoprenoid
18. Human lamin B contains a farnesylated cysteine residue
19. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG CoA reductase
20. Proliferative effect of mevalonate metabolites other than isoprenoids on cultured vascular smooth muscle cells
21. Lovastatin inhibits proliferation of rat mesangial cells
22. Cellular biology of human intimal hyperplastic stenosis
23. Actin isoform pattern as a marker of normal or pathological smooth muscle and fibroblastic tissues
24. The picomole determination of free and total cholesterol in cells in culture
25. Improved procedures for the determination of lipid phosphorus by malachite green
26. Lovastatin: a preliminary review of its pharmacodynamic properties and therapeutic use in hyperlipidaemia
27. The physiological disposition of lovastatin
28. Comparative pharmacokinetics and pharmacodynamics of pravastatin and lovastatin
29. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA registry of the National Heart, Lung and Blood Institute
30. Restenosis after successful coronary angioplasty in patients with single‐vessel disease
31. Restenosis after successful percutaneous transluminal coronary angioplasty: the Montreal Heart Institute experience
32. Multivalent feedback regulation of HMG CoA reductase: a control mechanism coordinating isoprenoid synthesis and cell growth
33. Role of cholesterolgenesis and isprenoid synthesis in DNA replication and cell growth
34. Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and Swiss 3T3 cells stimulated to divide by platelet derived growth factor
35. Isoprenoid regulation of cell growth: identification of mevalonate labelled compounds inducing DNA synthesis in human breast cancer cells depleted of serum and mevalonate
36. Evidence for isopentenyl adenine modification of a cell cycle regulated protein
37. Linkage of the isoprenoid synthesis pathway with induction of DNA synthesis in mouse lymphcytes. Effects of compactin on mitogen induced lymphocytes in serum free medium
38. Defective macromolecule biosynthesis and cell cycle progression in a mammalian cell starved from mevalonate
39. The role of N‐6 isopentenyl adenine in tumor cell growth
40. All ras proteins are polyisoprenlyated but only some are palmitoylated
41. Genetic and pharmacological suppresion of oncogenic mutation in ras genes of yeast and humans
42. Evidence of modification of lamin B by a product of mevalonic acid
43. Incorporation of a product of mevalonic acid metabolism into proteins of Chinese hamster ovary cell nuclei
44. Lovastatin inhibits proliferation of rat mesangial cells
45. Abnormal growth regulation of vascular smooth muscle cells by heparin in patients with restenosis
46. The lovastatin restenosis trial group: background and methods for the lovastatin restenosis trial after percutaneous transluminal coronary angioplasty
47. Antisense c‐myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo